Page 89 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 89
Parallel Session: Cirrhosis and Complications 1 (Cont.) Hall C (Plenary)
ABSTRACT THE PREVALENCE AND MORTALITY OF ACUTE-ON-
O078 CHRONIC LIVER FAILURE DEFINED BY APASL VS. EASL-
17:30 - 17:45 CLIF CONSORTIUM: A MULTICENTER, RETROSPECTIVE
COHORT STUDY IN KOREA (KACLIF STUDY)
Do Seon Song, South Korea SCIENTIFIC PROGRAMME
ABSTRACT CALR SOMATIC MUTATIONS IN A PROSPECTIVE
O079 COHORT OF 308 PATIENTS WITH SPLANCHNIC VEIN
17:45 - 18:00 THROMBOSIS
Pierre-Emmanuel Rautou, France
Parallel Session: Autoimmune and Genetic Liver Disease Strauss 1
Chairs:
Ulrich Beuers, The Netherlands
Tom Karlsen, Norway
ABSTRACT EARLY CLINICAL FEATURES ASSOCIATED WITH
O080 LONG-TERM RISK OF TRANSPLANTATION IN PRIMARY
16:00 - 16:15 SCLEROSING CHOLANGITIS: RESULTS FROM THE UK-
PSC CONSORTIUM
ABSTRACT Elizabeth C. Goode, The United Kingdom
O081
16:15 - 16:30 VAP-1 IS ELEVATED IN PSC, CORRELATES WITH
CLINICAL OUTCOME AND EXHIBITS AMINE OXIDASE
ABSTRACT ACTIVITY IN A SUBSTRATE-DEPENDENT MANNER
O082 Palak J. Trivedi, The United Kingdom
16:30 - 16:45
THE GUT MICROBIOTA IN PRIMARY SCLEROSING
ABSTRACT CHOLANGITIS DIFFERS FROM THAT OF HEALTHY
O083 CONTROLS AND ULCERATIVE COLITIS PATIENTS
16:45 - 17:00 WITHOUT BILIARY DISEASE
Martin Kummen, Norway
ABSENCE OF BSEP/ABCB11 PROTECTS FROM
CHOLESTATIC LIVER AND BILE DUCT INJURY IN A
MOUSE MODEL OF SCLEROSING CHOLANGITIS
Claudia D. Fuchs, Austria
Vienna, Austria • April 22–26, 2015 89
ABSTRACT THE PREVALENCE AND MORTALITY OF ACUTE-ON-
O078 CHRONIC LIVER FAILURE DEFINED BY APASL VS. EASL-
17:30 - 17:45 CLIF CONSORTIUM: A MULTICENTER, RETROSPECTIVE
COHORT STUDY IN KOREA (KACLIF STUDY)
Do Seon Song, South Korea SCIENTIFIC PROGRAMME
ABSTRACT CALR SOMATIC MUTATIONS IN A PROSPECTIVE
O079 COHORT OF 308 PATIENTS WITH SPLANCHNIC VEIN
17:45 - 18:00 THROMBOSIS
Pierre-Emmanuel Rautou, France
Parallel Session: Autoimmune and Genetic Liver Disease Strauss 1
Chairs:
Ulrich Beuers, The Netherlands
Tom Karlsen, Norway
ABSTRACT EARLY CLINICAL FEATURES ASSOCIATED WITH
O080 LONG-TERM RISK OF TRANSPLANTATION IN PRIMARY
16:00 - 16:15 SCLEROSING CHOLANGITIS: RESULTS FROM THE UK-
PSC CONSORTIUM
ABSTRACT Elizabeth C. Goode, The United Kingdom
O081
16:15 - 16:30 VAP-1 IS ELEVATED IN PSC, CORRELATES WITH
CLINICAL OUTCOME AND EXHIBITS AMINE OXIDASE
ABSTRACT ACTIVITY IN A SUBSTRATE-DEPENDENT MANNER
O082 Palak J. Trivedi, The United Kingdom
16:30 - 16:45
THE GUT MICROBIOTA IN PRIMARY SCLEROSING
ABSTRACT CHOLANGITIS DIFFERS FROM THAT OF HEALTHY
O083 CONTROLS AND ULCERATIVE COLITIS PATIENTS
16:45 - 17:00 WITHOUT BILIARY DISEASE
Martin Kummen, Norway
ABSENCE OF BSEP/ABCB11 PROTECTS FROM
CHOLESTATIC LIVER AND BILE DUCT INJURY IN A
MOUSE MODEL OF SCLEROSING CHOLANGITIS
Claudia D. Fuchs, Austria
Vienna, Austria • April 22–26, 2015 89
